Product NDC: | 10544-606 |
Proprietary Name: | Ciprofloxacin hydrochloride |
Non Proprietary Name: | Ciprofloxacin hydrochloride |
Active Ingredient(s): | 500 mg/1 & nbsp; Ciprofloxacin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10544-606 |
Labeler Name: | Blenheim Pharmacal, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076089 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100517 |
Package NDC: | 10544-606-06 |
Package Description: | 6 TABLET in 1 BOTTLE (10544-606-06) |
NDC Code | 10544-606-06 |
Proprietary Name | Ciprofloxacin hydrochloride |
Package Description | 6 TABLET in 1 BOTTLE (10544-606-06) |
Product NDC | 10544-606 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ciprofloxacin hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100517 |
Marketing Category Name | ANDA |
Labeler Name | Blenheim Pharmacal, Inc. |
Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |